Skip to content
  1. Home/
  2. Media Center/
  3. Press releases /
  4. Medical technologies

Medical technologies

Johnson & Johnson MedTech Presents Pivotal 12-Month Effectiveness and Safety Data from SmartfIRE Study at 2025 EHRA Congress

SmartfIRE 12-month data demonstrated 86.9% effectiveness when utilized with high adherence to the recommended ablation workflow and significant quality of life improvements using the Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter1 Additional real-world evidence from company-funded REAL AF registry shows equivalent outcomes with zero or reduced fluoroscopy versus conventional approaches

Johnson & Johnson MedTech to Highlight Latest Advancements in Heart Disease Treatment with Impella at ACC.25

Impella heart pump upgraded to Class 2a in ACC/AHA treatment guideline for cardiogenic shock secondary to STEMI

Johnson & Johnson MedTech Launches the DUALTO™ Energy System for Use Across Surgical Treatment Approaches

The DUALTO™ electrosurgical generator is designed to offer a simplified user experience, access to Polyphonic™ Fleet digital device management, and flexible application of monopolar, bipolar, ultrasonic, and advanced bipolar energy devices for open and minimally invasive surgery DUALTO will be showcased at the Association of periOperative Registered Nurses Global Surgical Conference & Expo on April 5-8, 2025 The DUALTO Energy System recently received 510(k) clearance by the U.S. Food & Drug Administration1

Johnson & Johnson MedTech Announces Clearance of MONARCHTM QUEST for Enhanced Robotic-Assisted Bronchoscopy

Next-generation NVIDIA-powered AI navigation software elevates MONARCHTM Platform for Robotically Assisted Bronchoscopy

Johnson & Johnson MedTech Showcases New Era of Digital Orthopaedics at AAOS 2025

Building on last year’s momentum of 18 FDA 510(k) Clearances and 45 global product launches, the company accelerates innovation across joint reconstruction, trauma, spine, and more

Shockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified Lesions

Now available in the U.S., the Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter safely modifies and crosses occlusive or extremely narrowed calcific peripheral artery disease

Johnson & Johnson MedTech Celebrates Inaugural National Heart Recovery Awareness Day

Impella patients share stories of heart recovery at reunions, events across the country Launch of Boston’s first hands-only CPR kiosk with American Heart Association

Johnson & Johnson to Resume U.S. VARIPULSE™ Cases

Investigation found that VARIPULSE™ devices operate as intended Cases being performed in U.S. External Evaluation to resume and Instructions for Use to be updated